CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Revenue: | ||||
| Total revenue | $ 3,059,141 | $ 3,283,469 | $ 7,502,583 | $ 10,370,542 |
| Cost of revenue: | ||||
| Total cost of revenue | 380,104 | 442,285 | 1,193,782 | 1,532,033 |
| Gross profit | 2,679,037 | 2,841,184 | 6,308,801 | 8,838,509 |
| Operating expenses: | ||||
| Research and development costs | 581,941 | 711,273 | 1,943,446 | 2,032,360 |
| Selling and marketing | 887,967 | 1,610,635 | 3,202,311 | 4,267,010 |
| General and administrative | 826,556 | 633,954 | 2,400,561 | 2,129,921 |
| Gain on litigation settlement | 0 | (632,600) | 0 | (632,600) |
| Restructuring costs | 0 | 68,704 | 744 | 792,754 |
| Total operating expenses | 2,296,464 | 2,391,966 | 7,547,062 | 8,589,445 |
| Operating income (loss) | 382,573 | 449,218 | (1,238,261) | 249,064 |
| Gain on debt extinguishment | 0 | 0 | 0 | 754,000 |
| Interest and other expense | (111,399) | (84,049) | (430,630) | (544,625) |
| Income (loss) before income taxes | 271,174 | 365,169 | (1,668,891) | 458,439 |
| Income tax expense (benefit) | 49,802 | 16,529 | 150,369 | 63,804 |
| Net income (loss) | 221,372 | 348,640 | (1,819,260) | 394,635 |
| Less: Accrual of Series A redeemable convertible preferred stock dividends | 391,016 | 288,802 | 1,030,365 | 848,898 |
| Less: Accretion to redemption value of Series A redeemable convertible preferred stock | 40,023 | 13,517 | 90,420 | 285,814 |
| Net income (loss) attributable to common stockholders | $ 209,667 | $ 46,321 | $ (2,940,045) | $ (740,077) |
| Basic net income (loss) per share attributable to common stockholders | $ (0.03) | $ 0.01 | $ (0.41) | $ (0.12) |
| Diluted net income (loss) per share attributable to common stockholders | $ (0.03) | $ 0.01 | $ (0.41) | $ (0.12) |
| Weighted average basic shares outstanding | 7,111,801 | 6,990,723 | 7,095,096 | 6,324,370 |
| Weighted average diluted shares outstanding | 7,111,801 | 7,039,421 | 7,095,096 | 6,324,370 |
| Product Revenue | ||||
| Revenue: | ||||
| Total revenue | $ 1,568,110 | $ 1,547,013 | $ 3,125,936 | $ 5,288,747 |
| Cost of revenue: | ||||
| Total cost of revenue | 19,711 | 41,351 | 65,018 | 298,966 |
| Support and Services Revenue | ||||
| Revenue: | ||||
| Total revenue | 1,491,031 | 1,736,456 | 4,376,647 | 5,081,795 |
| Cost of revenue: | ||||
| Total cost of revenue | $ 360,393 | $ 400,934 | $ 1,128,764 | $ 1,233,067 |
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends). No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|